AstraZeneca contacted Gilead in May about a possible merger, according to Bloomberg. GettyKEY FACTSAstraZeneca contacted Gilead in May about a possible merger⁠—which would be the biggest healthcare deal ever⁠—without specifying terms, Bloomberg reported, citing unnamed sources familiar with the matter. “We don’t comment on rumors and speculation,” an AstraZeneca spokesman told Forbes; representatives for Gilead declined to comment. Most recently, AstraZeneca’s blood cancer drug Calquence showed improvement in a small number of Covid-19 patients. The announcement drew worldwide interest, including from Iranian hackers, who reportedly targeted Gilead through email scams and other cybersecurity attacks.

Source: Forbes June 07, 2020 13:41 UTC